Home › Crohn's Disease › Texas › San Antonio

Pag-aaral pangklinika para sa Crohn's Disease sa San Antonio, TX

Isang pag-aaral para sa Crohn's Disease ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa San Antonio. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Nagre-recruitPhase 2

Southern Star Research Institute /ID# 280822, San Antonio

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07697456

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

Nagre-recruitPhase 3

Southern Star Research Institute ( Site 0299), San Antonio

Lahat ng edad · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06651281

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Nagre-recruitPhase 3

Southern Star Research Institute ( Site 5000), San Antonio

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Nagre-recruitPhase 2

Sun Research Institute /ID# 266723, San Antonio
Southern Star Research Institute /ID# 278124, San Antonio

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06548542

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 2

Southern Star Research Institute, LLC, San Antonio

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06233461

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

Gastroenterology Research of America, LLC, San Antonio
Southern Star Research Institute, LLC, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 2/3

Southern Star Research Institute, LLC, San Antonio

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07196722

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Nagre-recruitPhase 3

Gastroenterology Research of San Antonio, San Antonio
Southern Star Research Institute, San Antonio

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 3

Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184944

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Nagre-recruitPhase 2

Southern Star Research Institute, San Antonio

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07483099

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Nagre-recruitPhase 2

Southern Star Research Institute, San Antonio

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07483073

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Nagre-recruitPhase 4

Gastroenterology Research of San Antonio, LLC, San Antonio
Southern Star Research Institute, LLC., San Antonio

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06045754

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

Nagre-recruitPhase 3

Southern Star Research Institute, LLC, San Antonio

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 27, 2026 · NCT06227910

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Nagre-recruitPhase 2

Southern Star Research Institute, LLC, San Antonio

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT06456593

Pag-aaral para sa Crohn's Disease sa ibang lungsod

Iba pang pag-aaral sa San Antonio

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.